Press release
Breast Biopsy Market worth $1,094 million by 2025 - Leading Key Players are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US)
Breast Biopsy Market
Browse and in-depth TOC on "Breast Biopsy Market"
129 - Tables
37 - Figures
187 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr
The Technological advancements in the field of a breast biopsy and the rising incidence of breast cancer are the major factors driving the growth of this market. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other significant factors driving the growth of this market.
The biopsy needles segment accounted for the largest share of the market, by product, in 2019
Based on the product, the Breast Biopsy Market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products. In 2019, the biopsy needles held significant share of the market. The major share of this segment is primarily attributed to the rising incidence of breast cancer and the growing breast cancer diagnosis rate in developing countries. Moreover, rising preference to the minimally invasive procedures and favorable reimbursement scenario in both developed as well as developing countries will further drive the market growth.
Technological advancements to drive the growth of NGS-based biopsy segment during the forecast period
Based on guidance, the Breast Biopsy Market is segmented into image-guided biopsy and liquid biopsy. The liquid biopsy segment is further divided into NGS-based, PCR-based, and Microarray-based biopsy. Among these, the NGS-based biopsy segment is expected to register significant growth over the forecast period. Technological advancements and new product launches are other factors leading to segment growth. Companies operating in the segment, such as Illumina, Inc. (US), Thermo Fisher Scientific (US), and Fluxion Biosciences Inc. (US), are focusing on high R&D investment to deliver novel and advanced platforms for tumor diagnosis.
Needle biopsy segment is anticipated to hold major share of the global Breast Biopsy Market in terms of type
Based on type, the market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. In 2019, the needle breast biopsy held a major share of the market. Needle biopsy has replaced conventional excisional biopsy as the standard diagnostic procedure for breast cancer. Rising adoption of core needle biopsy by healthcare professionals due to advantages such as high sensitivity and specificity and technological advancements are driving the growth of the segment.
Get 10% Customization Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=189011805&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr
North America to hold a significant share of the Breast Biopsy Market during the forecast period
The market is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region accounted for the largest share of the market in 2019. The rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), presence of a favorable reimbursement scenario, and the rapidly increasing geriatric population in the region are some of the major factors driving the growth of the market in North America.
The major players operating in the Breast Biopsy Market are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US), Illumina, Inc. (US), and Fluxion Biosciences Inc (US), among others.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=189011805&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Biopsy Market worth $1,094 million by 2025 - Leading Key Players are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US) here
News-ID: 2222271 • Views: …
More Releases from MarketsandMarkets
eFuse Market is Projected to Reach $674 million by 2029 | Leading key players ar …
According to a research report "eFuse Market Type (Auto Retry, Latched), Package Type (Small Outline No Lead, Dual Flat No Leads, Quad Flat No Leads, Think Shrink Small Outline Package), Application, End User, & Region - Forecast to 2035" published by MarketsandMarkets, the eFuse market is projected to reach USD 674 million by 2029 from an estimated USD 557 million in 2024, at a CAGR of 3.9% during the forecast…
Battery Recycling Market worth $54.3 billion by 2030 | Key players Aqua Metals, …
According to recent market research the "Battery Recycling Market by Source (Automotive Batteries, Industrial Batteries, Consumer & Electronic Appliance Batteries), Chemistry (Lead Acid, Lithium-based, Nickel-based), Material (Metals, Electrolyte, Plastics) and Region - Global Forecast to 2030", is projected to grow from USD 26.9 billion in 2023 to USD 54.3 billion by 2030, at a CAGR of 10.5%. The mounting demand for electric vehicles to limit the rising pollution levels has…
Waterproofing Admixtures Market worth $8.0 billion by 2028 | Key players Sika AG …
According to recent market research the "Waterproofing Admixtures Market by Type (Pore Blocking Admixtures, Crystalline Admixtures, Densifier), Application (Residential, Commercial, Infrastructure), and Region (Asia Pacific, Europe, North America, MEA, South America) - Global Forecast to 2028", size was USD 5.3 billion in 2022 and is projected to reach USD 8.0 billion by 2028, at a CAGR of 7.4%, between 2023 and 2028. The market is projected to grow because of…
Combined Heat and Power Market Size to Grow $39.2 billion by 2029 | GE, Siemens …
According to a research report "Combined Heat and Power Market by Prime Mover (Gas Turbine, Steam Turbine, Reciprocating Engine, Fuel Cell, Microturbine), Capacity (Up to 10 MW, 10-150 MW, 151-300 MW, Above 300 MW), Fuel, End User and Region - Global Forecast to 2029" published by MarketsandMarkets, the Combined heat and power market is projected to reach USD 39.2 billion by 2029 from an estimated USD 30.4 billion in 2024,…
More Releases for Biopsy
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .
Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East…
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares
Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and…
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Needle Biopsy Industry 2018, Market Structure - By Type Fine-Needle Aspiration B …
Needle Biopsy Market information: by type (fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy) by utility (disposable, reusable), by applications (tumor, infection, Inflammation, others) - Global Forecast till 2023.
Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023.
KEY PLAYERS OF NEEDLE…
Global Breast Biopsy Devices Market In Japan: By Product - Biopsy Needles, Biops …
Researchmoz added Most up-to-date research on "Global Breast Biopsy Devices Market In Japan: By Product - Biopsy Needles, Biopsy Tables, Guidance Systems & Localization Wires" to its huge collection of research reports.
The global Breast Biopsy Devices market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.
Japan plays an…
